Simon Hirschmann
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.
Journal: Inflammatory bowel diseases
Published: June 05, 2025
Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.
Journal: Journal of Crohn's & colitis
Published: May 19, 2023
Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn's disease patient upon infliximab-induced lupus-like syndrome.
Journal: Therapeutic advances in gastroenterology
Published: May 13, 2021
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
Journal: Therapeutic advances in gastroenterology
Published: August 01, 2020
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis.
Journal: Therapeutic advances in gastroenterology
Published: June 19, 2020
Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Journal: The American journal of gastroenterology
Published: March 10, 2020
Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.
Journal: BMC gastroenterology
Published: September 19, 2019
Magnification endoscopy with optical chromoendoscopy shows strong correlation with histologic inflammation in patients with inflammatory bowel disease.
Journal: Endoscopy international open
Published: July 27, 2018
A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin.
Journal: Bone
Published: April 18, 2018
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Journal: Gut
Published: November 13, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: July 15, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles.
Journal: Frontiers in immunology
Published: April 25, 2017
Last Updated: 09/26/2026